Udintsev S N, Shakhov V P
Research Institute of Pharmacology, USSR Academy of Medical Sciences, Tomsk, USSR.
Neoplasma. 1991;38(3):323-31.
In experiment on rats with Pliss lymphosarcoma (PLS) it was shown that partial hepatectomy (PHE), a course application of Rhodiola rosea extract (RRE) or combined effects inhibit the growth of tumors by 37, 39 and 59%, respectively, and that of metastases by 42, 50 and 75%. In combined treatment the process of hepatic regeneration was completed in earlier terms versus the animals which underwent PHE, and proliferative activity of the tumor and metastases decreased by 15 and 59%, respectively, judging by the degree of 3H-thymidine incorporation into DNA of these tissues. The assessment of clonogenic activity of PLS cells taken in the animals of this group, using the method of diffusion chambers, revealed a significant decrease in this index versus the rats which underwent PHE or which were given RRE (number of colonies per chamber being 4.8 +/- 0.5; 8.6 +/- 0.9; 5.7 +/- 0.6, respectively; in control 13.8 +/- 1.5). The assumption that these effects are determined by factors originating from the regenerating liver was confirmed in experiments with double-layer agar systems. Inhibition of colony-forming activity of PLS cells was the maximum in application of the hepatocytes of the rats which underwent a complex of effects, as a feeder, versus the hepatocytes taken in intact or hepatectomized animals, or the rats which were given RRE (number of colonies per plate well being 4.6 +/- 0.3; 15.7 +/- 1.6; 7.4 +/- 0.8; 8.7 +/- 0.9, respectively; in the control 25.6 +/- 6.5). In experiments on mice with Ehrlich adenocarcinoma, the factors isolated from the liver of animals subjected to PHE against a background of RRE administration and from the liver of mice which were given RRE only, as well as operated or intact ones, inhibited the tumor growth to 63, 38, 35 and 21%, respectively.
在对患有普利斯淋巴肉瘤(PLS)的大鼠进行的实验中发现,部分肝切除术(PHE)、红景天提取物(RRE)的疗程应用或联合作用分别使肿瘤生长抑制37%、39%和59%,使转移抑制42%、50%和75%。与接受PHE的动物相比,联合治疗中肝再生过程在更早的时间完成,根据3H-胸腺嘧啶掺入这些组织DNA的程度判断,肿瘤和转移灶的增殖活性分别降低了15%和59%。使用扩散室法对该组动物体内获取的PLS细胞的克隆形成活性进行评估,结果显示该指标与接受PHE或给予RRE的大鼠相比显著降低(每个室的集落数分别为4.8±0.5;8.6±0.9;5.7±0.6;对照组为13.8±1.5)。双层琼脂系统实验证实了这些作用是由再生肝脏产生的因素所决定的假设。与取自完整或肝切除动物、或给予RRE的大鼠的肝细胞相比,将接受联合作用的大鼠的肝细胞作为饲养层应用时,对PLS细胞集落形成活性的抑制作用最大(每个平板孔的集落数分别为4.6±0.3;15.7±1.6;7.4±0.8;8.7±0.9;对照组为25.6±6.5)。在对艾氏腺癌小鼠的实验中,从在给予RRE背景下接受PHE的动物肝脏以及仅给予RRE的小鼠肝脏、手术或完整小鼠肝脏中分离出的因素,分别使肿瘤生长抑制63%、38%、35%和21%。